Davis G M, Forland S C, Cutler R E
Am J Kidney Dis. 1985 Sep;6(3):177-80. doi: 10.1016/s0272-6386(85)80023-8.
Oral cephalexin, 1 to 2 g daily for 3 days, was given to six stable, noninfected patients receiving maintenance continuous ambulatory peritoneal dialysis (CAPD). The peak serum concentration after a 2 g initial dose was between 73 and 123 mg/L. On the second and third day in five patients who received a 2 g daily oral dose, the serum concentrations were between 35 and 118 mg/L in serum obtained 1 to 1.5 hours after the dosing. Similar serum concentrations were seen in one patient who only received a 1 g oral dose on the second and third day. Cephalexin concentrations in the peritoneal dialysate reached a peak on the first day between 4 to 14 hours after the dose and were between 31 to 78 mg/L. During the second and third day, the highest cephalexin concentration was 118 mg/L and the lowest was 12 mg/L. The data are consistent with the feasibility of oral cephalexin for treatment of CAPD-associated peritonitis with microorganisms that are sensitive to these levels of cephalexin.
对6名接受维持性持续性非卧床腹膜透析(CAPD)的病情稳定、未感染的患者给予口服头孢氨苄,每日1至2克,共3天。初始剂量2克后的血清峰值浓度在73至123毫克/升之间。在5名每日口服2克剂量的患者的第二天和第三天,给药后1至1.5小时采集的血清中,血清浓度在35至118毫克/升之间。在第二天和第三天仅接受1克口服剂量的1名患者中观察到了类似的血清浓度。腹膜透析液中的头孢氨苄浓度在给药后第1天4至14小时达到峰值,在31至78毫克/升之间。在第二天和第三天,头孢氨苄的最高浓度为118毫克/升,最低浓度为12毫克/升。这些数据与口服头孢氨苄治疗对这些头孢氨苄水平敏感的微生物所致CAPD相关性腹膜炎的可行性一致。